Kirkland & Ellis LLP

Intellectual Property Litigation

Daniel is a partner in Kirkland's IP litigation team in London. Daniel has a broad practice which covers a wide range of technical fields, but is particularly noted for his experience in life science patent litigation, particularly in the pharmaceutical industry, diagnostics and the emerging fields of precision medicine and cell and gene therapy. He is also experienced in representing clients involved in complex SEP and FRAND licensing disputes.

In addition to UK litigation, Daniel is regularly called upon to assist clients in devising, coordinating and executing patent strategies for complex multijurisdictional disputes at a pan-European and global scale. With dual qualifications in law and biochemistry, and experience litigating in both Australia and Europe, Daniel is readily able to grasp highly technical material and the international dimensions of disputes which are often at the heart of effective strategies in blockbuster litigation for the most sophisticated clients. In recognition of his experience and leadership in the life sciences field, Daniel currently serves as the Vice-Chair of AIPPI’s standing committee on biotechnology.

2018 to present Kirkland & Ellis International LLP; 2015-2018 Allen & Overy LLP; 2012-2015 Clayton Utz

International Association for the Protection of Intellectual Property (AIPPI); EPLAW – European Patent Lawyers Association

University of Oxford (Postgraduate Diploma in Intellectual Property Law and Practice, 2016); The University of Sydney (LL.B., 2011); The University of Sydney (B.Sc., 2009)